These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6294692)

  • 1. Drug interactions at (pharmacodynamically active) receptor sites.
    Schou JS
    Pharmacol Ther; 1982; 17(2):199-210. PubMed ID: 6294692
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular and autonomic effects of muscle relaxants.
    Scott RP; Basta SJ
    Compr Ther; 1985 Mar; 11(3):56-67. PubMed ID: 2579761
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic and adrenergic receptors at sympathetic preganglionic nerve terminals.
    Nishi S
    Fed Proc; 1970; 29(6):1957-65. PubMed ID: 4394852
    [No Abstract]   [Full Text] [Related]  

  • 4. Spinal sympathetic neurons: possible sites of opiate-withdrawal suppression by clonidine.
    Franz DN; Hare DB; McCloskey KL
    Science; 1982 Mar; 215(4540):1643-5. PubMed ID: 6280276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of histamine on vascular sympathetic neuroeffector transmission.
    Powell JR
    J Pharmacol Exp Ther; 1979 Mar; 208(3):360-5. PubMed ID: 219175
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effects of pergolide on peripheral adrenergic neurotransmission in spontaneously hypertensive rats.
    Hahn RA
    Life Sci; 1981 Dec; 29(24):2501-9. PubMed ID: 6275226
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological actions of 6-hydroxydopamine.
    Kostrzewa RM; Jacobowitz DM
    Pharmacol Rev; 1974 Sep; 26(3):199-288. PubMed ID: 4376244
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of central GABA receptor agonism and antagonism on evoked diencephalic cardiovascular responses.
    Antonaccio MJ; Kerwin L; Taylor DG
    Neuropharmacology; 1978 Aug; 17(8):597-603. PubMed ID: 692821
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the electrophoretic application of sulfhydryl reagents to the end-plate receptors.
    Del Castillo J; Escobar I; Gijón E
    Int J Neurosci; 1971 Feb; 1(3):199-209. PubMed ID: 4349430
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of acetylcholine receptors by cobra toxin: electrophysiological studies.
    Lester HA
    Mol Pharmacol; 1972 Nov; 8(6):623-31. PubMed ID: 4344997
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of adrenergic transmission by acetylcholine.
    Story DF; Allen GS; Glover AB; Hope W; McCulloch MW; Rand MJ; Sarantos C
    Clin Exp Pharmacol Physiol; 1975; Suppl 2():27-33. PubMed ID: 171113
    [No Abstract]   [Full Text] [Related]  

  • 12. Histamine H1 and H2-receptors at a ganglionic synapse.
    Brimble MJ; Wallis DI
    Nature; 1973 Nov; 246(5429):156-8. PubMed ID: 4357166
    [No Abstract]   [Full Text] [Related]  

  • 13. [The pharmacologic properties of stereoisomers of 4-vinylethynyl- and 4-butyl-substituted decahydroquinololes-4].
    Kuz'mitskiĭ BB; Akhrem AA; Ukhova LI; Marochkin AP; Bludova GV
    Farmakol Toksikol; 1972; 35(6):665-8. PubMed ID: 4405616
    [No Abstract]   [Full Text] [Related]  

  • 14. Receptor occupancy dose--response curve suggests that phosphatidyl-inositol breakdown may be intrinsic to the mechanism of the muscarinic cholinergic receptor.
    Michell RH; Jafferji SS; Jones LM
    FEBS Lett; 1976 Oct; 69(1):1-5. PubMed ID: 992019
    [No Abstract]   [Full Text] [Related]  

  • 15. Presynaptic muscarinic cholinergic receptors.
    Sharma VK; Banerjee SP
    Nature; 1978 Mar; 272(5650):276-8. PubMed ID: 203868
    [No Abstract]   [Full Text] [Related]  

  • 16. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Do adrenergic fibres have muscarinic inhibitory receptors?
    Burn JH
    J Pharm Pharmacol; 1974 Mar; 26(3):212-5. PubMed ID: 4151085
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug interactions in antiarrhythmic therapy.
    Bigger JT; Giardina EG
    Ann N Y Acad Sci; 1984; 427():140-62. PubMed ID: 6331249
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the sympathetic cholinergic pathway in the neurogenic control of the release of tissue-type plasminogen activator into the blood].
    Bashkov GB; Sergeev IIu; Medvedeva NA; Makarov VA
    Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):60-7. PubMed ID: 1334882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.